Azstarys outperforms placebo for improving ADHD symptoms in children
Azstarys significantly improved ADHD symptoms in children aged 6 to 12 years vs. placebo, according to results of a randomized, controlled laboratory classroom study published in Journal of Child and Adolescent Psychopharmacology. “There remains a significant unmet need for more effective and safe medications to treat ADHD, especially medicines with early onset of action and duration